Agency Forms Undergoing Paperwork Reduction Act Review, 9615-9616 [E9-4720]

Download as PDF 9615 Federal Register / Vol. 74, No. 42 / Thursday, March 5, 2009 / Notices EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Number of respondents Form name Total burden hours Average hourly wage rate* Total cost burden Patient satisfaction survey ............................................................................. Focus groups ................................................................................................. 300 2.5 60 39 $19.29 37.50 $1,157 1,463 Total ........................................................................................................ 302.5 99 na 2,620 * The hourly wage for the patient surveys is based on the national average wage. The hourly wage for the focus groups is based upon the weighted mean of the average wages for physicians ($58.76, n=45), clinical administrative staff ($17.64, n=30) and other clinical staff ($25.48, n=30). National Compensation Survey: Occupational Wages in the United States, U.S. Department of Labor, Bureau of Labor Statistics. June 2007, Summary 07–03, https://www.bls.gov/ncs/ocs/sp/ncblO9lO.pdf. Accessed December 10, 2008. Estimated Annual Costs to the Federal Government Exhibit 3 shows the estimated total and annualized cost for this two-year evaluation. The total cost is $155,110 and includes $23,267 for project development, $32,573 for data collection activities, $31,022 for data processing and analysis, $15,511 for the publication of results, $12,408 for project management and $40,329 for overhead. EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST Cost component Total cost Annualized cost Project Development ....................................................................................................................................................... Data Collection Activities ................................................................................................................................................. Data Processing and Analysis ......................................................................................................................................... Publication of Results ...................................................................................................................................................... Project Management ........................................................................................................................................................ Overhead ......................................................................................................................................................................... $23,267 32,573 31,022 15,511 12,408 40,329 $11,633 16,287 15,511 7,756 6,204 20,164 Total .......................................................................................................................................................................... 155,110 77,555 jlentini on PROD1PC65 with NOTICES Request for Comments In accordance with the above-cited Paperwork Reduction Act legislation, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research, quality improvement and information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. VerDate Nov<24>2008 16:49 Mar 04, 2009 Jkt 217001 Dated: February 24, 2009. Carol M. Clancy, Director. [FR Doc. E9–4515 Filed 3–4–09; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–09–08AR] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–4766 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Proposed Project CDC Cervical Cancer Study (CX3)— New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is the only organized national screening program in the United States that offers breast and cervical cancer screening to underserved women. Screening policies for cervical cancer in the program include an annual Pap test until a woman has had three consecutive normal Pap tests. However, human papillomavirus (HPV) DNA testing is not currently a reimbursable expense under NBCCEDP guidelines, therefore adopting HPV DNA testing along with Pap testing in women over 30 could help the program better utilize resources by extending the screening interval of women who are cytology negative and HPV test negative, which is estimated to be 80–90% of women. CDC proposes to conduct a pilot study at 18 clinics in the state of Illinois in order to assess the feasibility, acceptability and barriers to use the HPV DNA test in conjunction with Pap E:\FR\FM\05MRN1.SGM 05MRN1 9616 Federal Register / Vol. 74, No. 42 / Thursday, March 5, 2009 / Notices test screening. Clinics will be assigned to an intervention group or a control group, matched on clinic attributes such as geographical location (urban, rural), HPV policy, and hospital versus nonhospital status, provider specialty mix, patient volume, and racial/ethnic characteristics of the patient population. Clinics in the intervention group will receive HPV DNA tests to administer to eligible patients presenting for a routine Pap test, as well as a multi-component educational intervention involving both health care providers and patients. Clinics in the control group will receive the HPV tests for eligible patients but will not receive the educational interventions involving health care providers and patients. OMB approval is requested for the first three years of a planned five-year study period. Information will be collected primarily from clinical care providers, clinic coordinators, and a sample of women between the ages of 35 and 60 who visit one of the participating clinics for routine cervical cancer screening. The results of this study will provide information about knowledge, attitudes, beliefs, and cervical cancer screening practices involving low-income, underserved women. The findings will help inform policy regarding the HPV DNA test on a national level for cervical cancer screening in the NBCCEDP. There are no costs to respondents other than their time. The total estimated annualized burden hours are 1,006. ESTIMATED ANNUALIZED BURDEN HOURS No. of respondents Type of respondent Form name Clinic Coordinators .......................................... Initial Clinic Survey ......................................... Follow-up Clinic Survey ................................. Baseline Provider Survey ............................... Follow-up Provider Survey ............................. Patient Screening Script ................................ Patient Enrollment Form ................................ Baseline Patient Survey ................................. Follow-up Patient Survey ............................... Health Care Providers .................................... Patients ........................................................... Dated: February 27, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–4720 Filed 3–4–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [30Day–09–08AV] jlentini on PROD1PC65 with NOTICES Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. 16:49 Mar 04, 2009 Jkt 217001 Cost and Follow-up Assessment of Administration on Aging (AoA)— Funded Fall Prevention Programs for Older Adults—New—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description Centers for Disease Control and Prevention VerDate Nov<24>2008 Proposed Project NCIPC seeks to examine cost of implementing each of the three AoAfunded fall prevention programs for older adults (Stepping On, Moving for Better Balance and Matter of Balance) and to assess the maintenance of fall prevention behaviors among participants six months after completing the Matter of Balance program. To assess the maintenance of fall prevention behaviors, CDC will conduct telephone interviews of 425 Matter of Balance program participants six months after they have completed the program. The interview will assess their knowledge and self-efficacy related to falls as taught in the course, their activity and exercise levels, and their reported falls both before and after the program. The results of the follow-up assessment will determine the extent to which preventive behaviors learned during the Matter of Balance program are maintained and can continue to PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 No. of responses per respondent 6 6 23 23 3,333 2,667 867 624 1 11 1 2 1 1 1 1 Average burden per response (in hours) 2 1 30/60 30/60 5/60 5/60 20/60 10/60 reduce fall risk. The cost assessment will calculate the lifecycle cost of the Stepping On, Moving for Better Balance, and Matter of Balance programs. It will also include calculating the investment costs required to implement each program, as well as the ongoing operational costs associated with each program. These costs will be allocated over a defined period of time depending on the average or standard amount of time these programs continue to operate (standard lifecycle analysis ranges from five to 10 years). As part of the lifecycle cost calculation, these data will allow us to compare program costs and to identify specific cost drivers, cost risks, and unique financial attributes of each program. Local program coordinators for the 200 sites in each of the AoA-funded states will collect the cost data using lifecycle cost spreadsheets that will be returned to CDC for analysis. The results of these studies will support the replication and dissemination of these fall prevention programs and enable them to reach more older adults. The Survey Screen takes 3 minutes, the survey instrument takes forty five minutes, and the cost tool takes two hours to complete. There are no costs to respondents other than their time. The total annual burden is 744 hours. E:\FR\FM\05MRN1.SGM 05MRN1

Agencies

[Federal Register Volume 74, Number 42 (Thursday, March 5, 2009)]
[Notices]
[Pages 9615-9616]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-4720]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-09-08AR]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-4766 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    CDC Cervical Cancer Study (CX3)--New--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) is the only organized national screening program in the 
United States that offers breast and cervical cancer screening to 
underserved women. Screening policies for cervical cancer in the 
program include an annual Pap test until a woman has had three 
consecutive normal Pap tests. However, human papillomavirus (HPV) DNA 
testing is not currently a reimbursable expense under NBCCEDP 
guidelines, therefore adopting HPV DNA testing along with Pap testing 
in women over 30 could help the program better utilize resources by 
extending the screening interval of women who are cytology negative and 
HPV test negative, which is estimated to be 80-90% of women.
    CDC proposes to conduct a pilot study at 18 clinics in the state of 
Illinois in order to assess the feasibility, acceptability and barriers 
to use the HPV DNA test in conjunction with Pap

[[Page 9616]]

test screening. Clinics will be assigned to an intervention group or a 
control group, matched on clinic attributes such as geographical 
location (urban, rural), HPV policy, and hospital versus non-hospital 
status, provider specialty mix, patient volume, and racial/ethnic 
characteristics of the patient population. Clinics in the intervention 
group will receive HPV DNA tests to administer to eligible patients 
presenting for a routine Pap test, as well as a multi-component 
educational intervention involving both health care providers and 
patients. Clinics in the control group will receive the HPV tests for 
eligible patients but will not receive the educational interventions 
involving health care providers and patients.
    OMB approval is requested for the first three years of a planned 
five-year study period. Information will be collected primarily from 
clinical care providers, clinic coordinators, and a sample of women 
between the ages of 35 and 60 who visit one of the participating 
clinics for routine cervical cancer screening.
    The results of this study will provide information about knowledge, 
attitudes, beliefs, and cervical cancer screening practices involving 
low-income, underserved women. The findings will help inform policy 
regarding the HPV DNA test on a national level for cervical cancer 
screening in the NBCCEDP.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 1,006.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      No. of      Average burden
          Type of respondent                    Form name             No. of       responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Clinic Coordinators...................  Initial Clinic Survey...               6               1               2
                                        Follow-up Clinic Survey.               6              11               1
Health Care Providers.................  Baseline Provider Survey              23               1           30/60
                                        Follow-up Provider                    23               2           30/60
                                         Survey.
Patients..............................  Patient Screening Script           3,333               1            5/60
                                        Patient Enrollment Form.           2,667               1            5/60
                                        Baseline Patient Survey.             867               1           20/60
                                        Follow-up Patient Survey             624               1           10/60
----------------------------------------------------------------------------------------------------------------


    Dated: February 27, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E9-4720 Filed 3-4-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.